Applied Spine Technologies to Restart U.S. Clinical Trial for Stabilimax NZ(R) Dynamic Spine Stabilization System
NEW HAVEN, Conn.--(BUSINESS WIRE)--Applied Spine Technologies (AST), Inc. (www.appliedspine.com), a medical device company focused on motion preservation of the lumbar spine, announces that it has received permission from the U.S. Food and Drug Administration (FDA) to proceed with enrollment in their IDE trial of the Stabilimax NZ® Dynamic Spine Stabilization System.